John B. Sullivan

Emergency Medicine
2701 E Elvira Rd
Tucson, AZ 85756

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Blinatumomab bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model.

Blinatumomab bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model.

Journal: Journal for immunotherapy of cancer
Published: May 23, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026